Skip to main content

Table 3 Characteristics of patients with posaconazole level monitoring

From: Analysis of posaconazole as oral antifungal prophylaxis in pediatric patients under 12 years of age following allogeneic stem cell transplantation

Characteristic

Posaconazole administration

 

2 x per day (n = 6)

3 x per day (n = 8)

 

No. of patients (%)

Gender

  

 Male

2 (33.3)

5 (62.5)

 Female

4 (66.6)

3 (37.5)

Age group

  

 < 6 years

3 (5.0)

6 (75.0)

 6-11 years

3 (5.0)

2 (25.0)

Donor

  

 MUD

2 (33.3)

3 (37.5)

 MMFD

2 (33.3)

5 (62.2)

 MFD

2 (33.3)

0 (0)

Primary diagnosis

  

 ALL

1 (16.7)

2 (25.0)

 Biphenotypic leukemia

0 (0)

1 (12.5)

 Solid tumors

1 (16.7)

0 (0)

 Aplastic anemia

2 (33.3)

1 (12.5)

 Neurometabolic diseases

1 (16.7)

1 (12.5)

 Immunodeficiency

1 (16.7)

3 (37.5)

Graft-versus-Host disease

  

 Grade I

2 (33.3)

2 (25.0)

 Grade II

0 (0)

2 (25.0)

 Grade III

0 (0)

0 (0)

 Grade IV

0 (0)

0 (0)

 Chronic limited

0 (0)

0 (0)

 Chronic extensive

0 (0)

0 (0)

  1. Abbreviation: ALL, indicates acute lymphoblastic leukemia; MFD, matched family donor; MMFD, mismatched family donor; MUD, matched unrelated donor.